Claudio Cerchione, MD, PhD, discusses the benefits of anti-CD38 quadruplet regimens for older patients with multiple myeloma.
Claudio Cerchione, MD, PhD
Advertisement
Articles by Claudio Cerchione, MD, PhD
An expert discusses the benefits of anti-CD38 quadruplet regimens for elderly multiple myeloma patients.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
4
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
5
